Growth Focused Foundation
- Using industry leading practices
- Chart of accounts
- Legal entities
- Organizational structures
- SOX compliant general ledger and accounts payable
- Efficient Procure-to-Pay foundation
- Rolling cash flow projections
- Clinical trial costing
- Joint venture reporting
- Core employee structures
- Real time “out of box” financial analytics
- Reduced risk and increased efficiencies
Ideal for Organizations
- Establishing a foundation for future growth
- Desiring real-time analytics to make
data-driven decisions - Seeking real time visibility into cash flow projections and burn rates
- Spending too much time making manual entries and tracking Procure-to-Pay processes
- Desiring a streamlined approach to tracking drug development costs
- Seeking to reduce human errors and risk
Foundational Package Plus
- Drug portfolio management and prioritization
- Expand Procure-to-Pay process with automation, AI and vendor management
- Expense planning
- Trial inventory management
- Critical recruiting needs such as sales reps and trial patients
- Clinical trial data management
- FDA submission data management
Ideal for Organizations
- Realizing the probability of FDA submissions are higher after positive
early phase results - Increasing spending with vendors and clinical trials
- Seeking quicker and better analytics
to make real time decisions - Wanting to eliminate inefficient expense management processes
- Processing large amounts of PO’s to match to invoices that are consuming critical resources
- Needing to streamline clinical trial tracking with analytics aiding prioritizing decisions
- With typical clinical trials exceeding 500 patients or have more than a few therapies coming out of R&D efforts
Value Realization Package Plus
- Manufacturing execution
- Validated process manufacturing
- Transportation management for tracing in transit environmental inventory data
- Quality
- Order management/fulfillment
- Cash receipts and application
Ideal for organizations
- Planning to manufacture
in-house or weighing in-house vs outsourced manufacturing decision - Expecting FDA decision/approvals and commercialization within 12-18 months
Foundational Package
Value Realization Package
Manufacturing Package